You are here

REGENERATION WITH PDGF TREATED OSTEOCONDUCTIVE MATERIALS

Award Information
Agency: Department of Health and Human Services
Branch: National Institutes of Health
Contract: N/A
Agency Tracking Number: 1R43DE014515-01
Amount: $176,905.00
Phase: Phase I
Program: SBIR
Solicitation Topic Code: N/A
Solicitation Number: N/A
Timeline
Solicitation Year: N/A
Award Year: 2001
Award Start Date (Proposal Award Date): N/A
Award End Date (Contract End Date): N/A
Small Business Information
1616 WESTGATE CIR
BRENTWOOD, TN 37027
United States
DUNS: N/A
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 SAMUEL LYNCH
 () -
Business Contact
Phone: (615) 595-5030
Research Institution
N/A
Abstract

DESCRIPTION: Platelet derived growth factor-BB (PDGF-BB) has been shown to
stimulate periodontal wound healing in both animals and humans. Certain Bone substitutes
have also been shown to enhance periodontal regeneration in both animal models and
in humans. The investigators have demonstrated that PDGF can be adsorbed to
that PDGF is slowly released in vitro. Addition of PDGF has been shown to enhance the
in vitro osteoblastic cell attachment and proliferation compared to untreated.
The hypothesis of the application is that PDGF treatment will enhance the periodontal
regenerative properties of these osteoconductive materials. The Specific Aims
of the application are to determine if combined with PDGF
promotes greater periodontal regeneration in the beagle dog than unmodified,
to determine the concentration of PDGF that when added to the
stimulates the greatest amount of regeneration, and to
determine if any abnormal healing responses in the periodontal defects such and
ankylosis and root resorption occur with the use of the PDGF treated .
PROPOSED COMMERCIAL APPLICATION: NOT AVAILABLE

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government